Verify it's really you

Please re-enter your password to continue with this action.

Published on Apr 10, 2026
Daily PIB Summaries
PIB Summaries 10 April 2026
PIB Summaries 10 April 2026

Content

  1. World Homoeopathy Day 2026

World Homoeopathy Day 2026


Why in News ?
  • World Homoeopathy Day (April 10) commemorates Samuel Hahnemann, highlighting India’s policy push toward AYUSH-based holistic healthcare systems.
  • Theme Homoeopathy for Sustainable Health aligns with preventive healthcarelow-cost treatment, and SDG-3 (Good Health and Well-being) goals.

Relevance

GS II (Governance & Social Sector)

  • Public health system strengthening through integration of AYUSH (homoeopathy) with primary healthcare (PHCs/CHCs).
  • Affordable healthcare delivery aligns with Article 21 (Right to Health – judicial interpretation) and welfare state obligations.
  • Institutional reforms via National Commission for Homoeopathy Act, 2020 replacing earlier regulatory framework.
  • Cooperative federalism in implementation of National AYUSH Mission (NAM) across states.

Practice Question

  • Integration of traditional medicine systems like Homoeopathy into Indias public health framework presents both opportunities and challenges.Critically examine. (250 words)

Static Background & Core Concepts
Concept of Homoeopathy
  • Based on principle like cures like, where substances causing symptoms are used in diluted form to treat similar symptoms.
  • Law of minimum dose emphasises ultra-dilution, stimulating self-healing mechanisms while reducing side effects.
  • Treatment is individualised, focusing on physical, mental, and emotional conditions, unlike disease-centric allopathy.
Historical evolution in India
  • Introduced in early 19th century (around 1810); gained acceptance after treatment of Maharaja Ranjit Singh (1839).
  • Institutional expansion included first hospital (1847, Tanjore) and growth in Bengal through Indian practitioners.
  • Post-independence reforms: Central Council of Homoeopathy (1973) and research council (1978) formalised education and regulation.
Institutional framework
Regulatory and research architecture
  • National Commission for Homoeopathy regulates education, ethics, curriculum, and practitioner registration.
  • Central Council for Research in Homoeopathy conducts clinical research, drug standardisation, and epidemic studies through nationwide units.
  • Pharmacopoeia Commission for Indian Medicine & Homoeopathy ensures quality, safety, and standardisation of drugs.
Infrastructure & capacity
  • India has 3.45 lakh registered doctors8,593 dispensaries277 institutions, and 34 research centres.
  • Expansion of educational capacity reflects growing demand and regulatory strengthening in AYUSH sector.
Policy support & government initiatives
Integration into public health
  • National AYUSH Mission (NAM) promotes co-location at PHCs and CHCs, improving accessibility and affordability.
  • Integration with NPCDCS supports chronic disease management using complementary therapeutic approaches.
Capacity building & research promotion
  • AYURSWASTHYA strengthens institutions and research excellence, while AYURGYAN focuses on training and skill enhancement.
  • Extra Mural Research Scheme provides up to ₹70 lakh funding, promoting scientific validation in epidemics and chronic diseases.
Drug quality & supply chain
  • AOGUSY scheme enhances manufacturing standards, WHO-GMP compliance, and regulatory quality control.
  • National Medicinal Plants Board (NMPB) supports 7,0007,500 medicinal plant species, ensuring sustainable raw material supply.
Public health role & emerging relevance
Preventive & holistic healthcare
  • Homoeopathy supports preventive, promotive, and chronic care, offering cost-effective and low-side-effect treatments.
  • IEC initiatives promote awareness, behavioural change, and community participation in preventive healthcare.
Epidemic preparedness
  • CCRH interventions used in dengue, chikungunya, encephalitis, and COVID-19 as prophylactic and adjunct therapies.
  • Example: Arsenicum album (COVID-19) used for ~5 lakh people across 136 centres, indicating large-scale public health application.
Global outreach
  • India promotes AYUSH through international cooperation, academic exchange, and research collaboration.
  • Strengthens India’s role as global hub for traditional medicine systems.
Challenges & issues
  • Scientific validation gap due to lack of large-scale, high-quality clinical trials meeting global biomedical standards.
  • Standardisation challenges in drug preparation, dosage, and practitioner-dependent treatment variability.
  • Integration gaps with modern medicine due to weak referral systems and coordination issues.
  • Global scepticism limits international acceptance and export potential of homoeopathic systems.
  • Weak monitoring mechanisms hinder evidence-based policymaking and outcome evaluation.
Way forward
  • Promote large-scale clinical trials and interdisciplinary research to strengthen scientific credibility.
  • Ensure global-standard regulation and quality assurance in drug manufacturing and safety protocols.
  • Develop integrative healthcare models combining AYUSH and allopathy, especially for chronic diseases and primary care.
  • Use digital health tools and data analytics for monitoring outcomes and improving policy decisions.
  • Expand global collaboration and knowledge exchange, positioning India as leader in traditional medicine systems.
Prelims pointers
  • Founder: Samuel Hahnemann; key text: Organon of Medicine.
  • National Commission for Homoeopathy Act, 2020 replaced earlier regulatory body.
  • CCRH operates through 30+ institutes, focusing on research and epidemic response.
  • PCIM&H acts as central drug testing and standardisation body for AYUSH medicines.
  • National AYUSH Mission integrates traditional systems into public healthcare infrastructure